Clinical Trials - May 10, 2017
Roche’s lung cancer drug receives approval by the Norwegian Medicines Agency
Clinical data from a phase III study of the lung cancer medicine, named Alecensa, also shows significant approved survival for lung cancer patients. The specific form of lung cancer this drugmis approved for, is called anaplastic lymfomkinase (ALK) -positive advanced non-small cell lung cancer (NSCLC). In Norway lung cancer affects about 3 035 people per […]
Agreement - October 20, 2015
DexTech in research agreement
Roche and DexTech have signed a research agreement with the aim to share DexTech’s know-how and proprietary glycosylation technology for applications in one of Roche’s oncology projects based on monoclonal antibodies. DexTech owns two globally granted patents relating to electrostatically modified dextrans for applications in cancer treatment. Roche will fund the research with EUR 50,000 […]
Acquisition - August 5, 2014
Roche to buy Santaris Pharma
Swiss Roche has announced that the company has agreed to acquire Danish biopharmaceutical firm Santaris Pharma for USD 450 million. The plan is to expand discovery and development of RNA-targeting medicines. Santaris Pharma has pioneered its proprietary Locked Nucleic Acid (LNA) platform that has contributed to an emerging era of RNA-targeting therapeutics, according to Roche which […]
Collaboration - July 29, 2014
AstraZeneca in new collaborations
AstraZeneca has entered a new collaboration with Dutch Qiagen and a partnership with Roche. The company has entered into a collaboration with Netherlands-based Qiagen to develop a non-invasive diagnostic test to identify non-small cell lung cancer (NSCLC) patients who are suitable for treatment with IRESSA, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that blocks […]
Collaboration - June 27, 2013
AstraZeneca in new collaborations
AstraZeneca join forces with Roche to share early data trial and teams up with Karolinska Institute for an integrated centre for cardiovascular and metabolic diseases. On June 26, AstraZeneca and Roche announced that the companies have entered a new collaboration to share a specific type of early research data related to drug design. The aim […]
Biotech Business - March 27, 2013
Roche and BioLamina start collaboration
Stockholm-based BioLamina recently signed a new R&D agreement with Roche to develop novel cell culture systems. The systems will be aimed at various applications, including stem cell research. BioLamina’s and Roche’s collaboration will focus on assessing laminin-based in-vitro cell culture matrices offering highly physiological microenvironments for living cells. According to BioLamina, laminins are proteins located […]
